-transparent.png){kind=logo}
Immunotherapeutic effects of soluble tumor specific transplantation antigens (TSTA) were studied, Crude 3M KC1 extract of C3H/He methylcholanthrene-induced sarcoma (F tumor) was purified by preparative isoelectric focusing (pIEF). The immunoprotective fraction (Fr. 15, pI 5.7-6.0) possessed about 50 fold greater activity than the crude 3M KC1 extract. Three weekly injections of optimal immunoprotective dose of Fr. 15 retarded the outgrowth of F cells and decreased the outgrowth and tumor incidence of rechallenged inoculation in mice completely resected established 1 cm tumor. Weekly injections of Fr. 15 resulted in decreased local recurrences. This therapeutic effect was immunologically specific. Fr. 15 alone did not show the therapeutic effects on the established tumor, but combined treatment with cyclophosphamide gave the increased survivals. A metastatic variant cell line (F-4) metastasized to the lung spontaneously after the resection of primary subcutaneous tumor. Therapeutic injections of Fr. 15 decreased the rates of spontaneous pulmonary metastasis of F-4. Since cross-immunoprotection tests revealed that F and F-4 share the common TSTA, the therapeutic effect of Fr. 15 upon pulmonary metastases might be due to improved host's specific immunity.
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
November 1980,
Journal of the National Cancer Institute,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
November 1982,
Journal of the National Cancer Institute,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
February 1970,
Cancer,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
September 1977,
Cancer research,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
February 1991,
International journal of cancer,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
October 1970,
Transplantation,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
January 1975,
Preparative biochemistry,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
October 1980,
Journal of immunology (Baltimore, Md. : 1950),
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
April 1971,
Journal of the National Cancer Institute,
T Tanaka, and
H Yamagishi, and
S Inaba, and
M Kobayashi, and
H Kurioka, and
K Naito, and
I Hashimoto
December 1982,
Proceedings of the National Academy of Sciences of the United States of America,
